ISIS Pharmaceuticals announced Friday that the company is changing its name to Ionis Pharmaceuticals.
The California-based biotech company will trade on the Nasdaq under the new ticker symbol “IONS,” replacing “ISIS,” according to CNBC.
The company did not cite the Islamic State of Iraq and Greater Syria, commonly known as ISIS, as the reason for the change in a statement issued by chief operating officer Lynne Parshall.
“Our goal is to create medicines that will save patients’ lives, and we are proud to be at the forefront of creating innovative medicines,” Parshall wrote in a statement. “We decided to change our company name because, when people see or hear our name, we want them to think about the life-saving medicines we are developing.”
More Must-Reads From TIME
- Jane Fonda Champions Climate Action for Every Generation
- Biden’s Campaign Is In Trouble. Will the Turnaround Plan Work?
- Why We're Spending So Much Money Now
- The Financial Influencers Women Actually Want to Listen To
- Breaker Sunny Choi Is Heading to Paris
- Why TV Can’t Stop Making Silly Shows About Lady Journalists
- The Case for Wearing Shoes in the House
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com